首页> 外文期刊>Pediatric Cardiology >Risk of Nephropathy After Consumption of Nonionic Contrast Media by Children Undergoing Cardiac Angiography: A Prospective Study
【24h】

Risk of Nephropathy After Consumption of Nonionic Contrast Media by Children Undergoing Cardiac Angiography: A Prospective Study

机译:接受心脏血管造影的儿童食用非离子造影剂后患肾病的风险:一项前瞻性研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Despite increasing reports on nonionic contrast media-induced nephropathy (CIN) in hospitalized adult patients during cardiac procedures, the studies in pediatrics are limited, with even less focus on possible predisposing factors and preventive measures for patients undergoing cardiac angiography. This prospective study determined the incidence of CIN for two nonionic contrast media (CM), iopromide and iohexol, among 80 patients younger than 18 years and compared the rates for this complication in relation to the type and dosage of CM and the presence of cyanosis. The 80 patients in the study consecutively received either iopromide (group A, n = 40) or iohexol (group B, n = 40). Serum sodium (Na), potassium (K), and creatinine (Cr) were measured 24 h before angiography as baseline values, then measured again at 12-, 24-, and 48-h intervals after CM use. Urine samples for Na and Cr also were checked at the same intervals. Risk of renal failure, Injury to the kidney, Failure of kidney function, Loss of kidney function, and End-stage renal damage (RIFLE criteria) were used to define CIN and its incidence in the study population. Accordingly, among the 15 CIN patients (18.75%), 7.5% of the patients in group A had increased risk and 3.75% had renal injury, whereas 5% of group B had increased risk and 2.5% had renal injury. Whereas 33.3% of the patients with CIN were among those who received the proper dosage of CM, the percentage increased to 66.6% among those who received larger doses, with a significant difference in the incidence of CIN related to the different dosages of CM (p = 0.014). Among the 15 patients with CIN, 6 had cyanotic congenital heart diseases, but the incidence did not differ significantly from that for the noncyanotic patients (p = 0.243). Although clinically silent, CIN is not rare in pediatrics. The incidence depends on dosage but not on the type of consumed nonionic CM, nor on the presence of cyanosis, and although CIN usually is reversible, more concern is needed for the prevention of such a complication in children.
机译:尽管在心脏手术期间住院的成年患者中非离子型造影剂诱发的肾病(CIN)的报道有所增加,但儿科研究仍然有限,甚至很少关注可能进行心血管造影的患者的诱发因素和预防措施。这项前瞻性研究确定了80岁以下18岁患者中两种非离子性对比剂(CM)碘普罗胺和碘海醇的CIN发生率,并比较了该并发症的发生率与CM的类型和剂量以及是否有紫relation。该研究中的80名患者连续接受了碘普罗胺(A组,n = 40)或碘海醇(乙组,n = 40)。在血管造影前24小时测量血清钠(Na),钾(K)和肌酐(Cr)作为基线值,然后在使用CM后每隔12、24和48小时再次测量。还以相同的时间间隔检查尿液中的Na和Cr样品。肾衰竭的风险,肾脏损伤,肾功能衰竭,肾功能丧失和终末期肾损害(RIFLE标准)被用于定义研究人群中的CIN及其发生率。因此,在15例CIN患者中(18.75%),A组患者中有7.5%的患病风险增加,而肾损伤中有3.75%,而B组中5%的患病风险是升高,而2.5%的是肾损伤。 CIN患者中有33.3%的患者接受了适当剂量的CM,而大剂量患者中这一比例上升到66.6%,而CIN的发生率与不同剂量的CM有显着差异(p = 0.014)。在15例CIN患者中,有6例患有发otic性先天性心脏病,但其发生率与非发otic性心脏病的发生率无显着差异(p = 0.243)。尽管临床上沉默,但CIN在儿科中并不罕见。发病率取决于剂量,而不取决于消耗的非离子型CM的类型,也不取决于紫osis的存在,尽管CIN通常是可逆的,但仍需要更多关注来预防儿童的这种并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号